Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 15/20 | 0.47 |
| ▸ | ACHE | P22303 | 13/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5069962 | 0.97 | BCHE (0.45) | BCHEACHEMAOBAPPC5AR1 | |
| SCHEMBL5134803 | 0.95 | BCHE (0.43) | BCHEACHEMAOBAPPC5AR1 | |
| SCHEMBL5135193 | 0.93 | BCHE (0.43) | BCHEACHEMAOBTP53MAPT | |
| SCHEMBL5136790 | 0.92 | ALOX5 (0.42) | BCHEACHEMAOBTP53MAPT | |
| SCHEMBL5135183 | 0.91 | PDE4B (0.39) | BCHEACHEMAPTC5AR1 | |
| SCHEMBL5135916 | 0.91 | TP53 (0.43) | BCHEACHETP53GAASMN1; SMN2 | |
| SCHEMBL5136469 | 0.90 | TP53 (0.41) | BCHEACHETP53MAPTGAA | |
| SCHEMBL5137859 | 0.90 | ALDH1A1 (0.41) | BCHEACHETP53GAASMN1; SMN2 | |
| SCHEMBL5137330 | 0.90 | BCHE (0.43) | BCHEACHEC5AR1 | |
| SCHEMBL5070121 | 0.89 | SMN1; SMN2 (0.41) | BCHEACHETP53GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |